TNYA — Tenaya Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $338.41m
- $233.77m
- 35
- 18
- 62
- 32
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 26.6 | 129 | 251 | 187 | 105 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 27.7 | 130 | 255 | 194 | 112 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9.57 | 17.2 | 54.7 | 62.7 | 53.3 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 38 | 148 | 314 | 279 | 171 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.12 | 5.04 | 21.8 | 24.2 | 22.7 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 8.7 | 8.72 | 35.7 | 35.6 | 31.1 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 29.3 | 139 | 279 | 243 | 139 |
Total Liabilities & Shareholders' Equity | 38 | 148 | 314 | 279 | 171 |
Total Common Shares Outstanding |